The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease
- Conditions
- Peripheral Nerve Disease
- Registration Number
- NCT06843642
- Lead Sponsor
- Wuhan Union Hospital, China
- Brief Summary
This is a retrospective observational cohort study (MRN-PND), aiming to explore the utility of contrast-enhanced MRN (ceMRN) compared to plain MRN in diagnosing peripheral nerve diseases and predicting the prognosis of patients with these conditions. Additionally, artificial intelligence (AI) methods are employed to enhance the diagnostic accuracy of MRN for peripheral nerve diseases and to precisely predict disease outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10000
- Patients who underwent MRN scanning at Wuhan Union Hospital between January 2015 and January 2025;
- Age > 18 years;
- Definitive clinical diagnosis (either healthy individuals or patients with a specific condition).
Exclusion criteria:
- Poor quality of imaging;
- Incomplete clinical data or loss to follow-up;
- Unclear clinical diagnosis.
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation analysis of MR information and diagnosis outcome 0.5 year The indicator is the area under the curve of the predict diagnosis outcome.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
🇨🇳Wuhan, Hubei, China